MedTrace Logo

Neutrophile Gelatinase Associated Lipocalin Evaluation in Septic Acute Kidney Injury

NCT01122225 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2010-05-31

No results posted yet for this study

Summary

Acute kidney injury (AKI) is a major organ failure in septic shock. Current medical tests (serum creatinine and urea) cannot identify AKI until approximately 48 hours after it occurs. Neutrophil gelatinase-associated lipocalin (NGAL) may be able to predict ischemic AKI more effectively and faster than serum creatinine and urea levels.

The purpose of this study is to take a blood sample from patients at admission and then at 24 and 48 hours after to test their plasma for NGAL and compare the NGAL levels to their creatinine and urea levels. The investigators hypothesize that NGAL is an earlier marker to classify the kidney failure as acute tubular necrosis or pre-renal azotemia than creatinine and urea.

Conditions

  • Acute Kidney Failure

Sponsors & Collaborators

  • Inverness Medical Innovations

    collaborator INDUSTRY

  • Université Victor Segalen Bordeaux 2

    lead OTHER

Principal Investigators

  • Fabrice Camou, MD · University Hospital, Bordeaux

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2010-05-31
Completion
2010-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01122225 on ClinicalTrials.gov